Single nucleotide polymorphisms and haplotypes of histamine N-methyltransferase in patients with gastric ulcer

Inflammation Research

Volumn 53, Issue 9, 2004, Pages 484-488

  Chen, G L ^a   Zhu, B ^a   Nie, W P ^a   Xu, Z H ^b   Tan, Z R ^a   Zhou, G ^a   Liu, J ^a   Wang, W ^c   Zhou, H H ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b JOHNSON AND JOHNSON   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Case control study; Gastric ulcer; Haplotype; Histamine N methyltransferase; Single nucieotide polymorphism

Indexed keywords

HISTAMINE METHYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; STOMACH ULCER;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HISTAMINE N-METHYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH ULCER;

EID: 6044272744     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-1290-0     Document Type: Article

References (37)

1. Altman DF. Drugs used in Gastrointestinal Disease. In: Basic & Clinical Pharmacology, Eighth Edition, eds Katzung BG, USA; McGraw-Hill Press, 2000; 1064-6.
2. Furutani K, Aihara T, Nakamura E, Tanaka S, Ichikawa A, Ohtsu H et al. Crucial role for histamine in regulating gastric acid secretion revealed with histidine decarboxylase-knockout mice. J Pharmacol Exp Ther 2003; 307: 331-8.
3. Barocelli E, Ballabeni V. Histamine in the control of gastric acid secretion: a topic review. Pharmacol Res 2003; 47(4): 299-304.
4. Warzecha Z, Dembinski A, Brzozowski T et al. Histamine in stress ulcer prophylaxis in rats. J Physiol Pharmacol 2001; 52(3): 407-21.
5. Ben Hamida A, Adesanya AA, Man WK, Spencer J. Histamine and tissue fibrinolytic activity in duodenal ulcer disease. Dig Dis Sci 1998; 43: 126-32.
6. Ohara S, Tsurui M, Watanabe T, Ichikawa T, Hotta K. Gastric mucosal damage accompanying changes in mucin induced by histamine in rats. Pharmacol Toxico 1995; 77: 397-401.
7. Troidl H, Rohde H, Lorenz W, Hafher G, Hamelmann H. Effect of selective gastric vagotomy on histamine concentration in gastric mucosa of patients with duodenal ulcer. Br J Surg 1978; 65: 10-6.
8. Man WK, Saunders JH, Ingoldby C, Spencer J. Effect of cimetidine on the amounts of histamine in the gastric mucosa of patients with gastric or duodenal ulcers. Gut 1981; 22: 923-6.
9. Peden NR, Callachan H, Shepherd DM, Wormsley KG. Gastric mucosal histamine and histamine methytltransferase in patients with duodenal ulcer. Gut 1982; 23: 58-62.
10. Man WK, Thompson JN, Baron JH, Spencer J. Histamine and duodenal ulcer: effect of omeprazole on gastric histamine in patients with duodenal ulcer. Gut 1986; 27: 418-22.
11. Lönroth H, Rosengren E, Olbe L, Lundell L. Histamine metabolism in human gastric mucosa: effect of pentagastrin stimulation. Gastroenterology 1990; 98: 921-8.
12. Lorenz W, Thon K, Barth H, Neugebauer E, Reimann HJ, Kusche J. Metabolism and function of gastric histamine in health and disease. J Clin Gastroenterol 1983; 5 Suppl 1: 37-56.
13. Rangachari PK. Histamine: mercurial messenger in the gut. Am J Physiol 1992; 262(1 Pt 1): G1-13.
14. Barth H, Troidl H, Lorenz W, Rohde H, Glass R. Histamine and peptic ulcer disease: histamine methyltransferase activity in gastric mucosa of control subjects and duodenal ulcer patients before and after surgical treatment. Agents Actions 1977; 7: 75-9.
15. Timoney AG, Man WK, Spencer J, Taylor H, Williams G. Histamine and duodenal ulceration in renal transplant recipients. Gut 1989; 30: 65-71.
16. Scott MC, Van Loon JA, Weinshilboum RM. Pharmacogenetics of N-methylation: Heritability of human erythrocyte histamine N-methylfransferase activity. Clin Pharmacol Ther 1988; 43: 256-62.
17. Price RA, Scott MC, Weinshilboum RM. Genetic segregation analysis of red blood cell (RBC) histamine N-methyltransferase (HNMT) activity. Genet Epidemiol 1993; 10: 123-31.
18. Preuss CV, Wood TC, Szumlanski CL, Raftogianis RB, Otterness DM, Girard B et al. Human histamine N-methylrransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol 1998; 53: 708-17.
19. Yan L, Galinsky RE, Bernstein JA, Liggett SB, Weinshilboum RM. Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics 2000; 10: 261-6.
20. Yan L, Szumlanski CL, Rice SR, Sobell JL, Lachman HM, Weinshilboum RM. Histamine N-methyltransferase functional polymorphism: lack of association with schizophrenia. Am J Med Genet 2000; 96: 404-6.
21. Chen GL, Wang H, Wang W, Xu ZH, Zhou G, He F et al. Histamine N-methyltransferase gene polymorphisms in Chinese and their relationship with enzyme activity in erythrocyte. Pharmacogenetics 2003; 13: 389-97.
22. Azuma T, Teramae N, Hayakumo T et al. Pepsinogen C gene polymorphisms associated with gastric body ulcer. Gut 1993; 34(4): 50-5.
23. Azuma T, Kohli Y, Kawai K. Deletion polymorphism in pepsinogen C gene is a potent risk factor for gastric body ulcer. J Gastroenterol 1994; 29 Suppl 7: 120-4.
24. Ohtaka Y, Azuma T, Konishi J, Ito S, Kuriyama M. Association between genetic polymorphism of the pepsinogen C gene and gastric body ulcer: the genetic predisposition is not associated with Helicobacter pylori infection. Gut 1997; 41(4): 469-74.
25. Garcia-Gonzalez MA, Lanas A, Santolaria S, Crusius JB, Serrano MT, Pena AS. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol 2001; 125(3): 368-75.
26. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction form population data. Am J Hum Genet 2001; 68: 978-89.
27. Calam J, Baron JH. ABC of the upper gastrointestinal tract: Pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ 2001; 323(7319): 980-2.
28. Harris A, Misiewicz JJ. ABC of the upper gastrointestinal tract. Management of Helicobacter pylori infection. BMJ 2001; 323 (7320): 1047-50.
29. Davidson S. Research suggests importance of haplotypes over SNPs. Nat Biotechnol. 2000; 18(11): 1134-5.
30. Zhao H, Pfeiffer R, Gail MH. Haplotype analysis in population genetics and association studies. Pharmacogenomics 2003; 4(2): 171-8.
31. Drysdale CM, McGraw DW, Stack CB et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97(19): 10483-8.
32. Wang L, Thomae B, Eckloff B, Wieben E, Weinshilboum R. Human histamine N-methyltransferase pharmacogenetics: gene resequencing, promoter characterization, and functional studies of a common 5′-flanking region single nucleotide polymorphism (SNP). Biochem Pharmacol 2002; 64: 699-710.
33. Kwiecien S, Brzozowski T, Konturek PC, Konturek SJ, Pawlik M, Pajdo R et al. Effect of central and peripheral actions of histamine and its metabolite N-alpha methyl histamine on gastric secretion and acute gastric lesions. J Physiol Pharmacol 2001; 52(4 Pt 1): 625-38.
34. Hocker M, Zhang Z, Koh TJ, Wang TC. The regulation of histidine decarboxylase gene expression.Yale J Biol Med 1996; 69(1): 21-33.
35. Wessler S, Hocker M, Fischer W et al. Helicobacter pylori activates the histidine decarboxylase promoter through a mitogen-activated protein kinase pathway independent of pathogenicity island-encoded virulence factors. J Biol Chem 2000; 275(5): 3629-36.
36. Prinz C, Zanner R, Gerhard M et al. The mechanism of histamine secretion from gastric enterochromaffin-like cells. Am J Physiol 1999; 277(5 Pt 1): C845-55.
37. Raychowdhury R, Zhang Z, Hocker M, Wang TC. Activation of human histidine decarboxylase gene promoter activity by gastrin is mediated by two distinct nuclear factors. J Biol Chem 1999; 274(30): 20961-9.